Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 63629-4698

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 63629-4698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
This is a graph showing the percentage reduction in CPS rate for patients taking Divalproex Sodium Delayed-Release Tablets compared to those taking placebo. The graph portrays the percentage of patients with improvement, no change, and worsening.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
The text describes a figure (Figure 2) that shows the percentage reduction in CPS rate for high and low dose divalproex sodium delayed-release tablets. The figure indicates that 50% of the patients have shown an improvement in CPS rate while some have shown no change or worsening of the condition.*
FDA Label Image

Figure 3. Mean Reduction In 4-week Migraine Headache Rates (Divalproex Fig3)

Figure 3. Mean Reduction In 4-week Migraine Headache Rates (Divalproex Fig3)
This seems to be a mix of numerical and textual data. It is unclear what this information represents, and without additional context, it is difficult to provide a useful description.*
FDA Label Image

Structure (Divalproex Str)

Structure (Divalproex Str)
FDA Label Image

Lbl636294698

Lbl636294698
This is a medication package of Divalproex Sodium 500mg ER Tablets that contains 60 tablets. The medication is manufactured by Aurobindo Pharma Limited and is packaged by Bryant Ranch Prepack Bunbank. It is recommended to store the medication at room temperature of 20°-25°C (68°-77°F) and keep it tightly closed. The medication can be used as a substitute for Depako-t, a medication with similar composition. The text includes product details such as the shape (gray oval) and the strength (500mg).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.